Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
17/11/202108h00UK RegulatoryOpen Orphan PLC GBP5.1m RSV contractLSE:HVOHvivo Plc
15/11/202113h19Alliance NewsAlliance NewsTRADING UPDATES: Billington project delays; Urban Logistics cash raiseLSE:HVOHvivo Plc
15/11/202108h00UK RegulatoryOpen Orphan PLC GBP1.5m Contract renewal for Venn Life SciencesLSE:HVOHvivo Plc
13/10/202114h25Alliance NewsAlliance NewsEXECUTIVE CHANGES: Halfords hires CFO; new Pendragon, Versarien chairsLSE:HVOHvivo Plc
13/10/202108h00UK RegulatoryOpen Orphan PLC Directorate ChangeLSE:HVOHvivo Plc
20/09/202113h02Alliance NewsAlliance NewsTRADING UPDATES: Christie Group and Open Orphan swing to profitLSE:HVOHvivo Plc
20/09/202108h00UK RegulatoryOpen Orphan PLC GBP5.7m Influenza human challenge study contract winLSE:HVOHvivo Plc
20/09/202108h00UK RegulatoryOpen Orphan PLC Half-year ReportLSE:HVOHvivo Plc
09/09/202108h00UK RegulatoryOpen Orphan PLC Notice of ResultsLSE:HVOHvivo Plc
07/09/202119h16Alliance NewsAlliance NewsTRADING UPDATES: Victoria growth continues; Renew to beat consensusLSE:HVOHvivo Plc
07/09/202115h59Alliance NewsAlliance NewsTRADING UPDATES: Marlowe buys Santia; Gaming Realms notes new launchLSE:HVOHvivo Plc
07/09/202108h00RNS Non-RegulatoryOpen Orphan PLC Positive results from RSV Human Challenge StudyLSE:HVOHvivo Plc
24/08/202110h31Alliance NewsAlliance NewsOpen Orphan shares lift on GBP8.1 million asthma study contract winLSE:HVOHvivo Plc
24/08/202110h05UK RegulatoryOpen Orphan PLC Second Price Monitoring ExtnLSE:HVOHvivo Plc
24/08/202110h00UK RegulatoryOpen Orphan PLC Price Monitoring ExtensionLSE:HVOHvivo Plc
24/08/202108h00UK RegulatoryOpen Orphan PLC GBP8.1m Asthma Human Challenge Study Contract WinLSE:HVOHvivo Plc
09/08/202108h00UK RegulatoryOpen Orphan PLC Malaria Human Challenge ModelLSE:HVOHvivo Plc
29/07/202108h00RNS Non-RegulatoryOpen Orphan PLC DNDi Phase II trial supportLSE:HVOHvivo Plc
22/07/202108h00RNS Non-RegulatoryOpen Orphan PLC NEJM Opinion PieceLSE:HVOHvivo Plc
21/07/202113h58UK RegulatoryOpen Orphan PLC Result of AGMLSE:HVOHvivo Plc
14/07/202116h07Alliance NewsAlliance NewsIN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPOLSE:HVOHvivo Plc
14/07/202116h01Alliance NewsAlliance NewsIN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debutLSE:HVOHvivo Plc
14/07/202110h06UK RegulatoryOpen Orphan PLC Directors' DealingsLSE:HVOHvivo Plc
14/07/202109h04UK RegulatoryOpen Orphan PLC AIM Schedule 1 update by Poolbeg Pharma plcLSE:HVOHvivo Plc
14/07/202108h01UK RegulatoryOpen Orphan PLC New Contract win for Open Orphan's Breda officeLSE:HVOHvivo Plc
14/07/202108h00UK RegulatoryOpen Orphan PLC COVID-19 Human Challenge Programme updateLSE:HVOHvivo Plc
09/07/202112h42Alliance NewsAlliance NewsOpen Orphan inks contract with AIM ImmunoTech to test Ampligen drugLSE:HVOHvivo Plc
09/07/202108h00UK RegulatoryOpen Orphan PLC HRV and Flu contractLSE:HVOHvivo Plc
30/06/202108h00UK RegulatoryOpen Orphan PLC 2020 Annual Report and 2021 AGM NoticeLSE:HVOHvivo Plc
17/06/202115h05Alliance NewsAlliance NewsOpen Orphan reports widened 2020 loss; Poolbeg mulls London floatLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO